CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC

Director · STANDARD BIOTOOLS INC.

Every open-market stock purchase CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought
$2.1M
Open-market buys
6
Companies
1
Last buy
Dec 4, 2025

Where the buys stand today

  • LAB
    STANDARD BIOTOOLS INC.
    −53.5% vs price paid

    6 purchases totalling $2.1M at an average of $1.86 per share; the stock last traded at $0.87. See all insider buying in LAB

    Avg price paid
    $1.86
    Latest price
    $0.87
    Market cap
    $338.4M

Cluster participation

Buys that landed within days of other insiders buying the same stock — the pattern this site exists to catch.

All reported buys

DateTickerSharesPriceValueFiling
Dec 4, 2025
LABcluster
150,000$1.45$217.5KSEC ↗
Dec 3, 2025
LABcluster
75,000$1.44$108.0KSEC ↗
Dec 2, 2025
LABcluster
125,000$1.42$177.5KSEC ↗
Aug 26, 2024
LABcluster
150,000$2.15$322.5KSEC ↗
Aug 23, 2024
LABcluster
292,100$2.13$622.2KSEC ↗
Aug 22, 2024
LABcluster
307,900$1.96$603.5KSEC ↗

Get alerted the next time CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC — or any insider — buys

We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.

About this data

Figures are parsed from CASDIN PRIVATE GROWTH EQUITY FUND GP, LLC's Form 4 filings on SEC EDGAR (CIK 1864554) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.